Loading…
In situ lyophilisation of nifedipine directly in hard gelatine capsules
Hydrophobic drugs present a challenge due to: (i) adhesion and agglomeration; hence the choice of the suitable processing technique to have the drugs into orally administered dosage forms is critical. (ii) Poor dissolution and poor aqueous solubility; hence poor bioavailability. A novel method which...
Saved in:
Published in: | Pharmaceutical development and technology 2013-12, Vol.18 (6), p.1379-1390 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c418t-1d5ff1a35fc0a5e927a9af1ba9f31bbe763dd6555e24b35e7ce547932c9964463 |
---|---|
cites | cdi_FETCH-LOGICAL-c418t-1d5ff1a35fc0a5e927a9af1ba9f31bbe763dd6555e24b35e7ce547932c9964463 |
container_end_page | 1390 |
container_issue | 6 |
container_start_page | 1379 |
container_title | Pharmaceutical development and technology |
container_volume | 18 |
creator | Crum, Matthew Elkordy, Amal Ali Zarara, Moataz Elkordy, Eman Ali |
description | Hydrophobic drugs present a challenge due to: (i) adhesion and agglomeration; hence the choice of the suitable processing technique to have the drugs into orally administered dosage forms is critical. (ii) Poor dissolution and poor aqueous solubility; hence poor bioavailability. A novel method which is in situ lyophilisation directly in hard gelatin capsule shells was used in this research to enhance the dissolution of nifedipine (a model hydrophobic drug) in the presence of co-povidone, Pluronic®F-127 and inulin as enhancement excipients (to the best of our knowledge those excipients have not been previously used with nifedipine in lyophilised forms).
Solutions of nifedipine and excipients in a range of concentrations (0.5, 1, 5 and 10%w/v) were prepared using a co-solvent system of tert- butyl alcohol/water mixture. These solutions were filled directly into bodies of size 000 hard gelatin capsule shells and freeze dried. Pure drug and all formulations were characterised by solubility, wetting studies and in vitro dissolution. Also, conformational integrity and thermal characteristics of nifedipine formulations were investigated using FT-IR spectroscopy and differential scanning calorimetry (DSC), respectively. The in situ lyophilisation of nifedipine with excipients, looks a promising method not only to improve the hydrophobic drug dissolution but also to be cost effective. |
doi_str_mv | 10.3109/10837450.2012.723718 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3109_10837450_2012_723718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1428773369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-1d5ff1a35fc0a5e927a9af1ba9f31bbe763dd6555e24b35e7ce547932c9964463</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMofv8DkR69dM1H0zQXRURXQfCi55CmEzeSTWrSIvvvbVkVvHiagXnmneFB6IzgBSNYXhLcMFFxvKCY0IWgTJBmBx1OI1HKpha7c9-wcmYO0FHO7xiTRmK-jw4olZJizg_R8jEU2Q1j4TexXznvsh5cDEW0RXAWOte7AEXnEpjBbwoXipVOXfEGfuKmidF9Hj3kE7Rntc9w-l2P0ev93cvtQ_n0vHy8vXkqTUWaoSQdt5Zoxq3BmoOkQkttSaulZaRtQdSs62rOOdCqZRyEAV4JyaiRsq6qmh2ji21un-LHCHlQa5cNeK8DxDErUtFGCMZqOaHVFjUp5pzAqj65tU4bRbCaFaofhWpWqLYKp7Xz7wtju4bud-nH2QRcbwEXbExr_RmT79SgNz4mm3QwLs_x_564-pOwAu2HldEJ1HscU5gE_v_jFxgqk5A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1428773369</pqid></control><display><type>article</type><title>In situ lyophilisation of nifedipine directly in hard gelatine capsules</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><source>BSC - Ebsco (Business Source Ultimate)</source><creator>Crum, Matthew ; Elkordy, Amal Ali ; Zarara, Moataz ; Elkordy, Eman Ali</creator><creatorcontrib>Crum, Matthew ; Elkordy, Amal Ali ; Zarara, Moataz ; Elkordy, Eman Ali</creatorcontrib><description>Hydrophobic drugs present a challenge due to: (i) adhesion and agglomeration; hence the choice of the suitable processing technique to have the drugs into orally administered dosage forms is critical. (ii) Poor dissolution and poor aqueous solubility; hence poor bioavailability. A novel method which is in situ lyophilisation directly in hard gelatin capsule shells was used in this research to enhance the dissolution of nifedipine (a model hydrophobic drug) in the presence of co-povidone, Pluronic®F-127 and inulin as enhancement excipients (to the best of our knowledge those excipients have not been previously used with nifedipine in lyophilised forms).
Solutions of nifedipine and excipients in a range of concentrations (0.5, 1, 5 and 10%w/v) were prepared using a co-solvent system of tert- butyl alcohol/water mixture. These solutions were filled directly into bodies of size 000 hard gelatin capsule shells and freeze dried. Pure drug and all formulations were characterised by solubility, wetting studies and in vitro dissolution. Also, conformational integrity and thermal characteristics of nifedipine formulations were investigated using FT-IR spectroscopy and differential scanning calorimetry (DSC), respectively. The in situ lyophilisation of nifedipine with excipients, looks a promising method not only to improve the hydrophobic drug dissolution but also to be cost effective.</description><identifier>ISSN: 1083-7450</identifier><identifier>EISSN: 1097-9867</identifier><identifier>DOI: 10.3109/10837450.2012.723718</identifier><identifier>PMID: 22992055</identifier><language>eng</language><publisher>England: Informa Healthcare</publisher><subject>Biological Availability ; Capsules - chemistry ; Chemistry, Pharmaceutical - methods ; Co-povidone ; dissolution ; Excipients - chemistry ; F-127 ; Freeze Drying - methods ; Gelatin - chemistry ; in situ lyophilisation ; inulin ; Inulin - chemistry ; nifedipine ; Nifedipine - chemistry ; Pluronic ; Poloxamer - chemistry ; Povidone - chemistry ; Solubility ; Solutions - chemistry ; Solvents - chemistry</subject><ispartof>Pharmaceutical development and technology, 2013-12, Vol.18 (6), p.1379-1390</ispartof><rights>2013 Informa Healthcare USA, Inc. 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-1d5ff1a35fc0a5e927a9af1ba9f31bbe763dd6555e24b35e7ce547932c9964463</citedby><cites>FETCH-LOGICAL-c418t-1d5ff1a35fc0a5e927a9af1ba9f31bbe763dd6555e24b35e7ce547932c9964463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22992055$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Crum, Matthew</creatorcontrib><creatorcontrib>Elkordy, Amal Ali</creatorcontrib><creatorcontrib>Zarara, Moataz</creatorcontrib><creatorcontrib>Elkordy, Eman Ali</creatorcontrib><title>In situ lyophilisation of nifedipine directly in hard gelatine capsules</title><title>Pharmaceutical development and technology</title><addtitle>Pharm Dev Technol</addtitle><description>Hydrophobic drugs present a challenge due to: (i) adhesion and agglomeration; hence the choice of the suitable processing technique to have the drugs into orally administered dosage forms is critical. (ii) Poor dissolution and poor aqueous solubility; hence poor bioavailability. A novel method which is in situ lyophilisation directly in hard gelatin capsule shells was used in this research to enhance the dissolution of nifedipine (a model hydrophobic drug) in the presence of co-povidone, Pluronic®F-127 and inulin as enhancement excipients (to the best of our knowledge those excipients have not been previously used with nifedipine in lyophilised forms).
Solutions of nifedipine and excipients in a range of concentrations (0.5, 1, 5 and 10%w/v) were prepared using a co-solvent system of tert- butyl alcohol/water mixture. These solutions were filled directly into bodies of size 000 hard gelatin capsule shells and freeze dried. Pure drug and all formulations were characterised by solubility, wetting studies and in vitro dissolution. Also, conformational integrity and thermal characteristics of nifedipine formulations were investigated using FT-IR spectroscopy and differential scanning calorimetry (DSC), respectively. The in situ lyophilisation of nifedipine with excipients, looks a promising method not only to improve the hydrophobic drug dissolution but also to be cost effective.</description><subject>Biological Availability</subject><subject>Capsules - chemistry</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Co-povidone</subject><subject>dissolution</subject><subject>Excipients - chemistry</subject><subject>F-127</subject><subject>Freeze Drying - methods</subject><subject>Gelatin - chemistry</subject><subject>in situ lyophilisation</subject><subject>inulin</subject><subject>Inulin - chemistry</subject><subject>nifedipine</subject><subject>Nifedipine - chemistry</subject><subject>Pluronic</subject><subject>Poloxamer - chemistry</subject><subject>Povidone - chemistry</subject><subject>Solubility</subject><subject>Solutions - chemistry</subject><subject>Solvents - chemistry</subject><issn>1083-7450</issn><issn>1097-9867</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMofv8DkR69dM1H0zQXRURXQfCi55CmEzeSTWrSIvvvbVkVvHiagXnmneFB6IzgBSNYXhLcMFFxvKCY0IWgTJBmBx1OI1HKpha7c9-wcmYO0FHO7xiTRmK-jw4olZJizg_R8jEU2Q1j4TexXznvsh5cDEW0RXAWOte7AEXnEpjBbwoXipVOXfEGfuKmidF9Hj3kE7Rntc9w-l2P0ev93cvtQ_n0vHy8vXkqTUWaoSQdt5Zoxq3BmoOkQkttSaulZaRtQdSs62rOOdCqZRyEAV4JyaiRsq6qmh2ji21un-LHCHlQa5cNeK8DxDErUtFGCMZqOaHVFjUp5pzAqj65tU4bRbCaFaofhWpWqLYKp7Xz7wtju4bud-nH2QRcbwEXbExr_RmT79SgNz4mm3QwLs_x_564-pOwAu2HldEJ1HscU5gE_v_jFxgqk5A</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Crum, Matthew</creator><creator>Elkordy, Amal Ali</creator><creator>Zarara, Moataz</creator><creator>Elkordy, Eman Ali</creator><general>Informa Healthcare</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>In situ lyophilisation of nifedipine directly in hard gelatine capsules</title><author>Crum, Matthew ; Elkordy, Amal Ali ; Zarara, Moataz ; Elkordy, Eman Ali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-1d5ff1a35fc0a5e927a9af1ba9f31bbe763dd6555e24b35e7ce547932c9964463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biological Availability</topic><topic>Capsules - chemistry</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Co-povidone</topic><topic>dissolution</topic><topic>Excipients - chemistry</topic><topic>F-127</topic><topic>Freeze Drying - methods</topic><topic>Gelatin - chemistry</topic><topic>in situ lyophilisation</topic><topic>inulin</topic><topic>Inulin - chemistry</topic><topic>nifedipine</topic><topic>Nifedipine - chemistry</topic><topic>Pluronic</topic><topic>Poloxamer - chemistry</topic><topic>Povidone - chemistry</topic><topic>Solubility</topic><topic>Solutions - chemistry</topic><topic>Solvents - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crum, Matthew</creatorcontrib><creatorcontrib>Elkordy, Amal Ali</creatorcontrib><creatorcontrib>Zarara, Moataz</creatorcontrib><creatorcontrib>Elkordy, Eman Ali</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical development and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crum, Matthew</au><au>Elkordy, Amal Ali</au><au>Zarara, Moataz</au><au>Elkordy, Eman Ali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In situ lyophilisation of nifedipine directly in hard gelatine capsules</atitle><jtitle>Pharmaceutical development and technology</jtitle><addtitle>Pharm Dev Technol</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>18</volume><issue>6</issue><spage>1379</spage><epage>1390</epage><pages>1379-1390</pages><issn>1083-7450</issn><eissn>1097-9867</eissn><abstract>Hydrophobic drugs present a challenge due to: (i) adhesion and agglomeration; hence the choice of the suitable processing technique to have the drugs into orally administered dosage forms is critical. (ii) Poor dissolution and poor aqueous solubility; hence poor bioavailability. A novel method which is in situ lyophilisation directly in hard gelatin capsule shells was used in this research to enhance the dissolution of nifedipine (a model hydrophobic drug) in the presence of co-povidone, Pluronic®F-127 and inulin as enhancement excipients (to the best of our knowledge those excipients have not been previously used with nifedipine in lyophilised forms).
Solutions of nifedipine and excipients in a range of concentrations (0.5, 1, 5 and 10%w/v) were prepared using a co-solvent system of tert- butyl alcohol/water mixture. These solutions were filled directly into bodies of size 000 hard gelatin capsule shells and freeze dried. Pure drug and all formulations were characterised by solubility, wetting studies and in vitro dissolution. Also, conformational integrity and thermal characteristics of nifedipine formulations were investigated using FT-IR spectroscopy and differential scanning calorimetry (DSC), respectively. The in situ lyophilisation of nifedipine with excipients, looks a promising method not only to improve the hydrophobic drug dissolution but also to be cost effective.</abstract><cop>England</cop><pub>Informa Healthcare</pub><pmid>22992055</pmid><doi>10.3109/10837450.2012.723718</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1083-7450 |
ispartof | Pharmaceutical development and technology, 2013-12, Vol.18 (6), p.1379-1390 |
issn | 1083-7450 1097-9867 |
language | eng |
recordid | cdi_crossref_primary_10_3109_10837450_2012_723718 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list); BSC - Ebsco (Business Source Ultimate) |
subjects | Biological Availability Capsules - chemistry Chemistry, Pharmaceutical - methods Co-povidone dissolution Excipients - chemistry F-127 Freeze Drying - methods Gelatin - chemistry in situ lyophilisation inulin Inulin - chemistry nifedipine Nifedipine - chemistry Pluronic Poloxamer - chemistry Povidone - chemistry Solubility Solutions - chemistry Solvents - chemistry |
title | In situ lyophilisation of nifedipine directly in hard gelatine capsules |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A10%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20situ%20lyophilisation%20of%20nifedipine%20directly%20in%20hard%20gelatine%20capsules&rft.jtitle=Pharmaceutical%20development%20and%20technology&rft.au=Crum,%20Matthew&rft.date=2013-12-01&rft.volume=18&rft.issue=6&rft.spage=1379&rft.epage=1390&rft.pages=1379-1390&rft.issn=1083-7450&rft.eissn=1097-9867&rft_id=info:doi/10.3109/10837450.2012.723718&rft_dat=%3Cproquest_cross%3E1428773369%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c418t-1d5ff1a35fc0a5e927a9af1ba9f31bbe763dd6555e24b35e7ce547932c9964463%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1428773369&rft_id=info:pmid/22992055&rfr_iscdi=true |